Farname Inc. in collaboration with Iranian Society of Gynecology Oncology


1 Collage of Medicine, University of Babylon, babil, Iraq

2 Department of Physiology, Collage of Medicine, University of Babylon, Babil, Iraq


One of the worldwide healthcare problem was Diabetes mellitus (DM), and the prevalence of this disease increases steadily particularly in pregnancy. The several metabolic disorders in the pregnancy were revealed by the placenta. The pathogenesis of diabetes mellitus is associated with hyperglycemia, insulin resistance, and oxidative stress, and it negatively impacts the mother-placenta-fetus system. This research aims to compare the amount of leptin expression, as well as its score and intensity, in the placentas of women with diabetes with those of healthy controls.
Materials and methods: In this work, we used a case-control methodology. Thirty women were diagnosed with diabetes and were placed in one group, while the other 40 served as a comparison. Primary monoclonal antibodies were used for the immunohistochemical analysis of leptin (Abcam, UK).
Results: The patients group showed the greatest percentage (23%) of placental expression of leptin. The expression of leptin was high in around 53% of the patient population. The intensity of leptin expression was significantly higher in DM patient than control groups (P>0.05). About 77% of patients group had moderate intensity of leptin expression while 37.5% of control group had no leptin expression.
Conclusion: Diabetes mellitus was related with alterations in expressions of leptin as metabolic placental factor. Leptin may be effect on pregnancy diverse disorders and pregnancy outcome.


  1. 1.Deputy NP, Kim SY, Conrey EJ, et al. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live Birth - United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2018;67(43):1201–1207. 2.hadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, et al. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010;33:664-669. 3.E Davies J, Pollheimer J, Yong HEJ, Kokkinos MI, Kalionis B, Knöfler M, et al. Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell Adhesion & Migration. 2016;10:310-321 4. Pilar Guadix, Antonio Pérez-Pérez, Teresa Vilariño-García, José L. Dueñas, Julieta Maymó, Cecilia Varone and Víctor Sánchez-Margalet .Leptin and Gestational Diabetes Mellitus. Open access peer-reviewed chapter.2020. 5. Pérez-Pérez A, Guadix P, Maymó J, Dueñas J, Varone C, Fernández-Sánchez M, et al. Insulin and leptin signaling in placenta from gestational diabetic subjects. Hormone and Metabolic Research. 2015;48:62-69. 6.Helmo FR, Lopes AMM, Carneiro ACDM, et al. Angiogenic and antiangiogenic factors in preeclampsia. Pathol Res Pract. 2018;214(1):7–14. 7.NgoabNanthiniJayabalanbcPolinHaghvirdizadehabCarlosSalomoncd . Role of adipose tissue in regulating fetal growth in gestational diabetes mellitus. Placenta.2020;1(102): 39-48 8.Park MJ, Lee DH, Joo BS, et al. Leptin, leptin receptors and hypoxia-induced factor-1α expression in the placental bed of patients with and without preeclampsia during pregnancy. Mol Med Rep. 2018;17(4):5292–5299. 9. Iriyama T, Wang W, Parchim NF, et al. Reciprocal upregulation of hypoxia-inducible factor-1α and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia. Faseb J. 2020;34(3):4041–4054. 10.Powe CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Current Diabetes Reports. 2017;17:12. 11. Uzelac PS, Li X, Lin J, et al. Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus. Placenta. 2010;31(7):581–588. 12. Kapustin RV, Drobintseva AO, Alekseenkova EN, et al. Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia. Arch Gynecol Obstet. 2020;301(2):437–445. 13. Antonio Pérez-Pérez, Teresa Vilariño-García, Pilar Guadix, José L. Dueñas, and Víctor Sánchez-Margalet.Leptin and Nutrition in Gestational Diabetes .Nutrients. 2020; 12(7): 1970. 14. Pérez-Pérez A, Toro A, Vilariño-Garcia T, Guadix P, Maymó J, Dueñas JL, et al. Leptin protects placental cells from apoptosis induced by acidic stress. Cell and Tissue Research. 2018. 15. Pérez-Pérez A, Toro AR, Vilarino-Garcia T, Guadix P, Maymó JL, Dueñas JL, et al. Leptin reduces apoptosis triggered by high temperature in human placental villous explants: The role of the p53 pathway. Placenta. 2016;42:106-113. 16. Fontana VA, Sanchez M, Cebral E, Calvo JC. Interleukin-1 beta regulates metalloproteinase activity and leptin secretion in a cytotrophoblast model. Biocell. 2010;34:37-43. 17. Pérez-Pérez A, Maymó JL, Gambino YP, Guadix P, Dueñas JL, Varone CL, et al. Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: Possible role of leptin. Hormone and Metabolic Research. 2013;45:436-442. 18. Powe CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Current Diabetes Reports. 2017;17:12. 19. Côté S, Gagné-Ouellet V, Guay SP, Allard C, Houde AA, Perron P, et al. PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. Clinical Epigenetics. 2016;8:72. 20. Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clinical Endocrinology. 2012;76:2-11. 21. Bednar AD, Beardall MK, Brace RA, Cheung CY. Differential expression and regional distribution of aquaporins in amnion of normal and gestational diabetic pregnancies. Physiological Reports. 2015;3:e12320. 22. Vilariño-García T, Pérez-Pérez A, Dietrich V, Guadix P, Dueñas JL, Varone CL, et al. Leptin upregulates aquaporin 9 expression in human placenta in vitro. Gynecological Endocrinology. 2018;34:175-177.